Skip to main content
. 2024 Aug 30;11:1424116. doi: 10.3389/fcvm.2024.1424116

Table 1.

Baseline characteristics.

Baseline no RVD Baseline RVD p-value
No RVD (n = 325) New-onset RVD (n = 106) Normalized RVD (n = 73) Residual RVD (n = 94) All groups
Age, years 72.0 (65.0–77.0) 72.5 (67.0–79.0) 71.0 (66.0–80.0) 73.0 (66.0–80.0) 0.256
Female 30.2 (98) 20.8 (22) 15.1 (11) 19.1 (18) 0 . 011
Body mass index, kg/m2 23.4 (20.3–26.6) 22.1 (19.9–24.7) 22.0 (19.6–24.6) 22.3 (19.0–24.7) <0.001
Body surface area, m2 1.6 (1.3–1.8) 1.5 (1.3–1.7) 1.5 (1.4–1.6) 1.6 (1.3–1.7) 0.059
NYHA functional class III or IV 95.4 (310) 98.1 (104) 98.6 (72) 98.9 (93) 0.262
Diabetes mellitus 20.9 (68) 18.9 (20) 24.7 (18) 36.2 (34) 0.012
Hypertension 60.0 (195) 67.0 (71) 68.5 (50) 79.8 (75) 0.004
Hypercholesterolaemia 24.3 (79) 25.5 (27) 27.4 (20) 39.4 (37) 0.036
Coronary artery disease 28.3 (92) 30.2 (32) 26.0 (19) 42.6 (40) 0.050
Percutaneous coronary intervention 3.1 (10) 2.8 (3) 5.5 (4) 5.3 (5) 0.525
Coronary artery bypass surgery 3.4 (11) 1.9 (2) 4.1 (3) 5.3 (5) 0585
Stroke or TIA 3.4 (11) 3.8 (4) 5.5 (4) 2.1 (2) 0.681
Peripheral vascular disease 40.3 (131) 38.7 (41) 41.1 (30) 43.6 (41) 0.911
Chronic obstructive pulmonary disease 8.0 (26) 8.5 (9) 13.7 (10) 14.9 (14) 0.146
Dialysis 23.7 (77) 17.9 (19) 21.9 (16) 23.4 (22) 0.660
Atrial fibrillation 20.9 (68) 26.4 (28) 24.7 (18) 28.7 (27) 0.366
Permanent pacemaker implant 3.4 (11) 5.7 (6) 1.4 (1) 6.4 (6) 0.289
STS score,% 6.7 (3.2–9.0) 6.2 (4.7–7.9) 7.1 (5.5–8.3) 7.7 (5.9–9.1) 0.083
EuroSCORE II,% 6.0 (2.9–8.5) 6.2 (4.0–7.8) 6.2 (5.5–7.9) 7.4 (6.0–8.6) 0.021

EuroSCORE II, European system for cardiac operative risk evaluation II; NYHA, New York Heart Association; RVD, right ventricular dysfunction; STS, society of thoracic surgeons; TIA, transient ischemic attack.

The bold p value means that the value is <0.05.